Hesson LB - Search Results

1

Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.

Ma SS, Henry CE, Llamosas E, Higgins R, Daniels B, Hesson LB, Hawkins NJ, Ward RL, Ford CE. Ma SS, et al. Among authors: hesson lb. Virchows Arch. 2017 Jan;470(1):99-108. doi: 10.1007/s00428-016-2019-5. Epub 2016 Sep 8. Virchows Arch. 2017. PMID: 27631337

2

ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration.

Ma SS, Srivastava S, Llamosas E, Hawkins NJ, Hesson LB, Ward RL, Ford CE. Ma SS, et al. Among authors: hesson lb. BMC Cancer. 2016 Jul 20;16:508. doi: 10.1186/s12885-016-2576-7. BMC Cancer. 2016. PMID: 27440078 Free PMC article.

3

Erratum to: Validation of specificity of antibodies for immunohistochemistry: the case of ROR2.

Ma SS, Henry CE, Llamosas E, Higgins R, Daniels B, Hesson LB, Hawkins NJ, Ward RL, Ford CE. Ma SS, et al. Among authors: hesson lb. Virchows Arch. 2016 Dec;469(6):717. doi: 10.1007/s00428-016-2036-4. Epub 2016 Oct 29. Virchows Arch. 2016. PMID: 27796585 No abstract available.

4

Integrated Genetic, Epigenetic, and Transcriptional Profiling Identifies Molecular Pathways in the Development of Laterally Spreading Tumors.

Hesson LB, Ng B, Zarzour P, Srivastava S, Kwok CT, Packham D, Nunez AC, Beck D, Ryan R, Dower A, Ford CE, Pimanda JE, Sloane MA, Hawkins NJ, Bourke MJ, Wong JW, Ward RL. Hesson LB, et al. Mol Cancer Res. 2016 Dec;14(12):1217-1228. doi: 10.1158/1541-7786.MCR-16-0175. Epub 2016 Sep 26. Mol Cancer Res. 2016. PMID: 27671336 Free article.

5

Epimutations and cancer predisposition: importance and mechanisms.

Hesson LB, Hitchins MP, Ward RL. Hesson LB, et al. Curr Opin Genet Dev. 2010 Jun;20(3):290-8. doi: 10.1016/j.gde.2010.02.005. Epub 2010 Mar 31. Curr Opin Genet Dev. 2010. PMID: 20359882 Review.

6

A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterations.

Metz AJ, Bourke MJ, Moss A, Dower A, Zarzour P, Hawkins NJ, Ward RL, Hesson LB. Metz AJ, et al. Among authors: hesson lb. Eur J Gastroenterol Hepatol. 2013 Mar;25(3):319-26. doi: 10.1097/MEG.0b013e32835b57e7. Eur J Gastroenterol Hepatol. 2013. PMID: 23354161

7

Establishing the clinical utility of epigenetic markers in cancer: many challenges ahead.

Zarzour P, Hesson LB, Ward RL. Zarzour P, et al. Among authors: hesson lb. Epigenomics. 2013;5(5):513-23. doi: 10.2217/epi.13.53. Epigenomics. 2013. PMID: 24059798

8

The evidence for functional non-CpG methylation in mammalian cells.

Patil V, Ward RL, Hesson LB. Patil V, et al. Among authors: hesson lb. Epigenetics. 2014 Jun;9(6):823-8. doi: 10.4161/epi.28741. Epub 2014 Apr 9. Epigenetics. 2014. PMID: 24717538 Free PMC article. Review.

9

Discrimination of pseudogene and parental gene DNA methylation using allelic bisulfite sequencing.

Hesson LB, Ward RL. Hesson LB, et al. Methods Mol Biol. 2014;1167:265-74. doi: 10.1007/978-1-4939-0835-6_18. Methods Mol Biol. 2014. PMID: 24823784

10

Epigenetic inactivation of the candidate tumor suppressor USP44 is a frequent and early event in colorectal neoplasia.

Sloane MA, Wong JW, Perera D, Nunez AC, Pimanda JE, Hawkins NJ, Sieber OM, Bourke MJ, Hesson LB, Ward RL. Sloane MA, et al. Among authors: hesson lb. Epigenetics. 2014 Aug;9(8):1092-100. doi: 10.4161/epi.29222. Epub 2014 May 16. Epigenetics. 2014. PMID: 24837038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters